fda deadline tirzepatide Lawsuit Against the FDA: Why, and What's Next? The Tirzepatide Shortage Is Over:

(Link) Twin Health secured $50M to enhance its digital twin technology platform, which aims to revolutionize personalized health management

Brooke Boyarsky Pratt, the CEO of the obesity-care startup Knownwell, said likely cuts to federal Medicaid funding under a second Trump administration and potential crackdowns on weight-loss drugs may limit patient access to that care

Learn more about medically managed GLP-1 programs at npocwellness.com #GLP1 #Semaglutide #WeightManagement #MedicalWellness #IVTherapy #ConciergeWellness #BaltimoreBusiness #MarylandWellness #WellnessMembership #PeptideTherapy #PreventiveMedicine To view or add a comment, sign in When people hear about GLP-1 agonists, weight loss is often the first benefit that comes to mind

Depending on how much weight you want or need to lose most clients will stay on the medication for 6-12 months just to make sure they can accomplish their goals